EVANGELISTA, LAURA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.492
AS - Asia 1.007
EU - Europa 861
Continente sconosciuto - Info sul continente non disponibili 9
SA - Sud America 5
OC - Oceania 2
Totale 9.376
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.475
CN - Cina 716
IT - Italia 375
VN - Vietnam 262
FI - Finlandia 202
DE - Germania 81
GB - Regno Unito 57
SE - Svezia 45
IE - Irlanda 44
UA - Ucraina 18
CA - Canada 14
HK - Hong Kong 12
NL - Olanda 10
EU - Europa 7
BE - Belgio 6
IN - India 6
BR - Brasile 3
FR - Francia 3
HU - Ungheria 3
MX - Messico 3
RO - Romania 3
RU - Federazione Russa 3
SG - Singapore 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AR - Argentina 2
CH - Svizzera 2
IR - Iran 2
JP - Giappone 2
MD - Moldavia 2
PL - Polonia 2
AL - Albania 1
AT - Austria 1
AU - Australia 1
BD - Bangladesh 1
GE - Georgia 1
MY - Malesia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 9.376
Salva come PNG Salva come JPEG
Città #
Fairfield 1.604
Woodbridge 694
Ashburn 662
Houston 605
Seattle 577
Cambridge 544
Wilmington 431
Medford 334
Princeton 334
Chandler 313
Des Moines 263
Dong Ket 261
Ann Arbor 232
San Diego 220
Helsinki 195
Beijing 153
Roxbury 96
Jinan 89
Nanjing 61
Padova 56
Dublin 44
Shenyang 38
Rome 37
Guangzhou 34
Zhengzhou 32
Nanchang 31
Haikou 29
Hebei 27
Ningbo 25
Hangzhou 23
Changsha 20
Milan 18
Taizhou 15
Kharkiv 14
New York 14
Ogden 14
Borås 13
Fuzhou 13
Taiyuan 13
Jiaxing 12
Tianjin 11
Lanzhou 10
Bologna 9
London 9
Malo 9
Norwalk 9
Conegliano 8
Rockville 8
Hefei 6
Hounslow 6
Palermo 6
Shanghai 6
Acton 5
Boardman 5
Catania 5
Frankfurt am Main 5
Ottawa 5
Prescot 5
Varese 5
Vicenza 5
Bergamo 4
Brescia 4
Enterprise 4
Lappeenranta 4
Montreal 4
Pignone 4
Redwood City 4
Trento 4
Trieste 4
Brendola 3
Brussels 3
Chiswick 3
Columbus 3
Corvara 3
Kilburn 3
Legnaro 3
Liverpool 3
L’Aquila 3
Marcallo con Casone 3
Mazzano Romano 3
Monza 3
Naples 3
New Bedfont 3
Salerno 3
Turin 3
Americana 2
Amsterdam 2
Berlin 2
Budapest 2
Buenos Aires 2
Camerino 2
Cantu 2
Chicago 2
Chisinau 2
Enschede 2
Ferrara 2
Florence 2
Frosinone 2
Genoa 2
Hong Kong 2
Totale 8.441
Salva come PNG Salva come JPEG
Nome #
10-Year Clinical Experience with 18F-Choline PET/CT: An Italian Multicenter Retrospective Assessment of 3343 Patients 149
Nuovi radiofarmaci per diagnosi e terapia: il rame 64 111
PET/MRI in prostate cancer: a systematic review and meta-analysis 109
18F-FDG PET/CT and urothelial carcinoma: Impact on management and prognosis—a multicenter retrospective study 106
Could semiquantitative FDG analysis add information to the prognosis in patients with stage II/III breast cancer undergoing neoadjuvant treatment? 98
MP79-02 EVALUATION OF THE PROGNOSTIC IMPACT OF 18F-CHOLINE PET/CT IN PATIENTS WITH SKELETAL RECURRENCE PROSTATE CANCER 95
Radiolabelled choline and FDG PET/CT: two alternatives for the assessment of lymph node metastases in patients with upper urinary tract urothelial carcinoma 87
THE WAR IS OPENED: PSMA VS. 64CuCL2 VS. CHOLINE PET/CT 82
18F-choline PET/CT and PET/MRI in primary and recurrent hyperparathyroidism: a systematic review of the literature 82
Microdosimetric measurements in the thermal neutron irradiation facility of LENA reactor 78
Comparison between18F-Dopa and 18F-Fet PET/CT in patients with suspicious recurrent high grade glioma: A literature review and our experience 76
Utility of Choline Positron Emission Tomography/Computed Tomography for Lymph Node Involvement Identification in Intermediate- to High-risk Prostate Cancer: A Systematic Literature Review and Meta-analysis. 72
[18F]FDG PET/MRI in rectal cancer 70
Diagnostic and prognostic impact of fluorine-18-fluorodeoxyglucose PET/CT in preoperative and postoperative setting of breast cancer patients 69
Diagnostic imaging to detect and evaluate response to therapy in bone metastases from prostate cancer: current modalities and new horizons 68
68Ga-dotatoc vs.18F-FDG vs. radiolabelled PSMA PET/CT in renal cancer patients 68
Re: Michael S. Hofman, Nathan Lawrentschuk, Roslyn J. Francis, et al. Prostate-specific Membrane Antigen PET-CT in Patients with High-risk Cancer Before Curative-intent Surgery or Radiotherapy (proPSMA): A Prospective, Randomized, Multicenter Study. Lancet 2020;395:1208–16 68
Is radiocholine PET/CT already clinically useful in patients with prostate cancer? 63
Role of molecular imaging in the management of patients affected by inflammatory bowel disease: State-of-the-art 62
18 F-Choline PET/CT in Leptomeningeal Breast Cancer Metastases 62
18F-FDG or 68Ga/18F-PSMA PET/CT in recurrent renal cancer? 62
Novel Nuclear Medicine Imaging Applications in Immuno-Oncology 62
A Solitary Metastasis for a Malignant Schwannoma in the Gallbladder Detected by 18F-FDG PET/CT 61
Molecular Imaging of Pulmonary Inflammation and Infection 60
The role of 18f-fdg pet/ct in staging and prognostication of mantle cell lymphoma: An italian multicentric study 60
The effects of androgen deprivation therapy on the 18F-choline uptake in prostate cancer patients undergoing neoadjuvant treatment 59
FDG avidity at PET/CT during adjuvant hormonal therapy in patients with breast cancer 58
Biochemical and Pathophysiological Premises to Positron Emission Tomography With Choline Radiotracers 58
Follow-up of patients with early breast cancer: is it time to rewrite the story? 58
C-reactive protein levels are associated with paraoxonase polymorphism L55M in patients undergoing cardiac SPECT imaging 57
PET/CT And The Response To Immunotherapy In Lung Cancer 57
Diagnostic and prognostic value of 18F-FDG PET/CT in recurrent germinal tumor carcinoma 56
18F-DOPA and 18F-FDG PET/CT, scintigraphic localization and radioguided surgery of recurrent medullary thyroid cancer: two case reports 56
Targeting prostate cancer with the anti-PSMA scFvD2B: a theranostic promise for nuclear medicine 56
64CuCl2 PET/CT in a hyperfunctioning parathyroid gland 56
What are the best ways to reduce the false-positive rate of 18F-FDG PET/CT in patients with breast cancer? 55
18F-DOPA and 18F-FDG PET/CT, scintigraphic localization and radioguided surgery of recurrent medullary thyroid cancer: two case reports 54
Can FDG PET/CT monitor the response to hormonal therapy in breast cancer patients? 53
Performance of FDG-PET/CT in solitary pulmonary nodule based on pre-test likelihood of malignancy: results from the ITALIAN retrospective multicenter trial 53
Management of hyperglycemia in oncological patients scheduled for an FDG-PET/CT examination 53
18F-FDG PET/MRI in adult sarcomas 51
Relation between wall thickening on gated perfusion SPECT and functional recovery after coronary revascularization in patients with previous myocardial infarction 50
Suspicious for recurrent low and high grade glioma and indeterminate MRI: the role of 18F-DOPA PET/CT 50
Mismatch between perfusion and metabolism in locally advanced breast cancer 49
Discordance rate between radiolabelled choline PET/CT and bone scintigraphy in detecting bone metastases in patients with prostate cancer: a meta-analysis 49
Approaches for Assessment of Response of Bone Metastases to Therapies 48
Tumour markers and FDG PET/CT for prediction of disease relapse in patients with breast cancer 48
Cardiovascular risk stratification of diabetic patients 48
Estimation of coronary flow reserve by sestamibi imaging in type 2 diabetic patients with normal coronary arteries 47
Assessment of the risk and its temporal variation in patients undergoing stress cardiac spect imaging late after percutaneous coronary intervention 47
The bone pathway: 223Ra-dichloride 47
Ga-68 DOTA-peptides and F-18 FDG PET/CT in patients with neuroendocrine tumor: A review 47
PET/MR in recurrent glioblastoma patients treated with regorafenib: [18F]FET and DWI-ADC for response assessment and survival prediction 47
Predictive and prognostic value of 18F-DOPA PET/CT in patients affected by recurrent medullary carcinoma of the thyroid 46
Somatostatin Receptor PET/CT Imaging for the Detection and Staging of Pancreatic NET: A Systematic Review and Meta-Analysis 46
Diagnostic and prognostic evaluation of fluorodeoxyglucose positron emission tomography/computed tomography and its correlation with serum cancer antigen-125 (CA125) in a large cohort of ovarian cancer patients 45
Usefulness of stress cardiac single-photon emission computed tomographic imaging late after percutaneous coronary intervention for assessing cardiac events and time to such events 45
COMPARISON BETWEEN THE DIAGNOSTIC ACCURACIES OF 18F-FLUORODEOXYGLUCOSE (FDG) POSITRON EMISSION TOMOGRAPHY (PET)/COMPUTED TOMOGRAPHY (CT) AND MORPHOLOGICAL IMAGING IN RECURRENT UROTHELIAL CARCINOMAS: A RETROSPECTIVE, MULTI-CENTER STUDY 45
Positron emission tomography with computed tomography imaging (PET/CT) for the radiotherapy planning definition of the biological target volume: PART 2 45
The ability of 18F-choline PET/CT to identify local recurrence of prostate cancer 44
Assessment of the risk and its temporal variation in patients undergoing stress cardiac SPECT imaging late after percutaneous coronary intervention . 44
Reclassification of cardiovascular risk by myocardial perfusion imaging in diabetic patients with abnormal resting electrocardiogram 44
Targeted therapy with Radium-223 of bone metastases 44
Economic burden of the management of metastatic castrate-resistant prostate cancer in Italy: A cost of illness study 44
Interpretative reproducibility of cardiac stress imaging: direct comparison between dobutamine echocardiography and single photon emission computed tomography. 43
Clinical results and economic considerations of 68Ga-PSMA and radiolabeled choline in prostate cancer 43
GUIDELINES ON RADIOISOTOPE TREATMENT OF LYMPHOMAS 43
Use of a portable gamma camera for guiding surgical treatment in locally advanced breast cancer in a post-neoadjuvant therapy setting 43
How has the management of medullary thyroid carcinoma changed with the advent of 18F-FDG and non-18F-FDG PET radiopharmaceuticals 43
PET/CT imaging in gynecologic malignancies: A critical overview of its clinical impact and our retrospective single center analysis 43
Prostate-specific antigen and radiolabelled choline PET/CT for the assessment of response to therapy: synergy or conflicting? 42
Reply to Egesta Lopci, Arturo Chiti, and Massimo Lazzeri's Letter to the Editor re: Laura Evangelista, Alberto Briganti, Stefano Fanti, et al. New Clinical Indications for 18F/11C-choline, New Tracers for Positron Emission Tomography and a Promising Hybrid Device for Prostate Cancer Staging: A Systematic Review of the Literature. Eur Urol 2016;70:161-75 42
Multicentric study on ¹⁸F-FDG-PET/CT breast incidental uptake in patients studied for non-breast malignant purposes 42
New issues for copper-64: from precursor to innovative pet tracers in clinical oncology 42
FDG-PET/CT imaging in gynecologic cancers: Is there an advance on patient management? 42
Cardiac performance during exercise in hypertensive patients without ventricular hypertrophy 42
Published guidelines on radioisotopic treatments of thyroid diseases 42
Diagnostic Applications of Nuclear Medicine: Prostatic Cancer 42
Head-to-head comparison between 18F-FDG PET/CT and PET/MRI in breast cancer 42
Positron emission tomography with computed tomography imaging (PET/CT) for the radiotherapy planning definition of the biological target volume: PART 1 42
18F-DOPA and 18F-FDG PET/CT, scintigraphic localization and radioguided surgery of recurrent medullary thyroid cancer: two case reports 42
Comparison of MRI, PET, and 18F-choline PET/MRI in patients with oligometastatic recurrent prostate cancer 42
The role of PET/CT in the evaluation of patients affected by limbic encephalitis: A systematic review of the literature 41
Comparative studies of radiolabeled choline positron emission tomography, histology of primary tumor and other imaging modalities in prostate cancer: a systematic review and meta-analysis 41
Gleason score at diagnosis predicts the rate of detection of 18F-choline PET/CT performed when biochemical evidence indicates recurrence of prostate cancer: experience with 1,000 patients 41
Diagnostic and Prognostic Value of 18F-FDG PET/CT in Male Breast Cancer: Results From a Bicentric Population 41
Standardized uptake value (SUV) by positron emission tomography/computed tomography (PET/CT) as a prognostic variable in metastatic breast cancer (MBC) 41
Boron Neutron Capture Therapy 41
GUIDELINES ON RADIOISOTOPE TREATMENT OF LIVER CANCER AND LIVER METASTASES WITH INTRA-ARTERIAL RADIOACTIVE COMPOUNDS 41
Imaging of glycolysis with 18F-FDG PET 41
Pet and spect imaging in the SARS-CoV-2 pandemic 41
Predictive value of (18)F-FDG PET/CT in restaging patients affected by ovarian carcinoma: a multicentre study 40
Myocardial perfusion imaging and risk classification for coronary heart disease in diabetic patients. The IDIS study: a prospective, multicentre trial 40
Risk-related 18F-FDG PET/CT and new diagnostic strategies in patients with solitary pulmonary nodule: the ITALIAN multicenter trial 40
The role of PET/CT in the evaluation of patients with urothelial cancer: a systematic review and meta-analysis 40
The multicenter ITALIAN trial assess the performance of FDG-PET/CT related to pre-test cancer risk in patients with solitary pulmonary nodules and introduces a segmental thoracic diagnostic strategy 40
Early detection of prostate cancer relapse by biochemistry and diagnostic imaging 40
Prognostic and diagnostic value of [18F]FDG-PET/CT in restaging patients with small cell lung carcinoma: an Italian multicenter study 40
MUNES: a MUltidisciplinar Neutron Source for BNCT and Nuclear Waste characterization 39
Incremental prognostic value of cardiac single-photon emission computed tomography after nitrate administration in patients with ischemic left ventricular dysfunction 39
Totale 5.428
Salva come PNG Salva come JPEG
Categoria #
all - tutte 43.373
article - articoli 32.046
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.828
Totale 77.247
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201925 0 0 0 0 0 0 0 0 0 0 17 8
2019/20202.762 16 1 21 900 217 96 147 203 284 489 152 236
2020/20212.240 108 201 205 197 80 77 118 310 146 296 165 337
2021/20222.759 57 536 173 127 165 112 133 188 230 80 156 802
2022/20231.289 626 87 18 53 103 132 9 61 101 28 47 24
2023/2024621 27 101 70 81 65 78 85 35 31 39 9 0
Totale 9.745